This healthcare technology company is disrupting the diabetes market with innovative technologies that patients love. More than 34 million Americans have diabetes and an additional 88 million are at ...
The US FDA has cleared a new “basal insulin dose optimizer” function for the Dexcom G7 15-day continuous glucose monitor (CGM), which is set to launch separately on December 1, 2025. The “Smart Basal” ...
Three of the top diabetes tech companies put forward new clinical data this week, making the case for their continuous glucose monitors and insulin pumps as they look to expand their reach among ...
More than 34 million Americans have diabetes and an additional 88 million are at risk of developing the disease, according to the American Diabetes Association. In this world of data, automation, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results